tirzepatide vs semaglutide dosage comparison Evaluating Dose Titration in and for Weight Loss: A Retrospective Academic Call Center Study Resource Guide GLP-1 medications in

@thekatieduke is here to unpack the science behind the latest study

Leading Players in the GLP-1 Market Novo Nordisk 38.72% Ozempic Wegovy Rybelsus Eli Lilly 28.41% Mounjaro Zepbound Sanofi 8.76% 4 AstraZeneca 6.62% 5 GSK 4.95% 6 Regeneron 3.27% 7 Pfizer 2.61% 8 Amgen 1.98% 9 Sun Pharma 1.52% Boehringer Ingelheim 1.24% Together, Novo Nordisk and Eli Lilly account for more than 67% of the market, highlighting the intense competition between the two companies that currently lead the obesity and diabetes treatment revolution

Recent news around the dividend and GLP-1 expansion has arrived alongside strong share price momentum, with CVS Healths 90-day share price return of 36.43% and...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans, pharmacy chains, and the federal government.